- Publikační typ
- abstrakt z konference MeSH
Shape memory alloys (SMA) are materials with specific electric, mechanic and thermal qualities originating in their microscopic structure and as such are used to design so-called Smart structures. In biomedicine, they are used mostly for their shape memory properties during intravasal surgery. The commonly used SMA material for biomedical purposes is Nitinol, a nickel-titanium alloy that exhibits, especially when annealed, among other properties also superelasticity and high resistivity with strain changes. This makes it suitable for usage in strain gauge sensors. In this work, NiTi annealed wires were used to create a strain gauge sensor, which exploits their unique properties. The properties of these sensors were then described using a climatic chamber, stretching device and a set of weights. Those properties were then compared to similar sensors, that are using different principles. The development, that followed, used these sensors in particular biomedical applications.
- MeSH
- automatizované zpracování dat metody přístrojové vybavení MeSH
- biomedicínské technologie MeSH
- biomedicínský výzkum MeSH
- chytré materiály analýza škodlivé účinky terapeutické užití MeSH
- elektrická impedance MeSH
- kvantitativní vztahy mezi strukturou a aktivitou MeSH
- manometrie metody přístrojové vybavení MeSH
- nikl škodlivé účinky terapeutické užití MeSH
- slitiny s tvarovou pamětí * chemie klasifikace škodlivé účinky MeSH
- titan škodlivé účinky terapeutické užití MeSH
- Publikační typ
- práce podpořená grantem MeSH
- přehledy MeSH
Východiská: Podstatou moderných postupov liečby onkologických pacientov je v dnešnej dobe zacielenie konkrétnych molekúl zapojených do bunkovej signalizácie asociovanej s nádorovou iniciáciou a progresiou. Úspech uvedeného prístupu závisí od správne zvoleného diagnostického testu s vysokou citlivosťou, ktorý identifikuje výskyt a hladinu vybraných biomarkerov u pacientov pre selekciu tých, ktorí budú na liečivo reagovať a budú z neho benefitovať. Vývoj nových technológií a modernizácia tých známych, prispievajú k inováciám molekulárnej charakterizácie karcinómov, ktorá umožňuje detekciu mutačného stavu pacienta s vysokou citlivosťou a špecifickosťou. Cieľ: V práci diskutujeme o využití polymerázovej reťazovej reakcie (PCR) tretej generácie, tzv. droplet digitálnej PCR (ddPCR), v molekulárnej diagnostike karcinómov. Podľa štúdií uvedených v našom prehľade predstavuje ddPCR sľubný nástroj pri vytváraní genetického profilu pacientov s onkologickým ochorením. Optimalizácia a presná validácia môžu preto umožniť postupnú implementáciu ddPCR do klinickej praxe v oblasti onkológie.
Background: Nowadays, modern treatment methods for cancer patients are based on targeting specific molecules involved in cellular signaling system associated with tumor initiation and progression. The success of such approach depends on a correctly chosen diagnostic test with high sensitivity that identifies the occurrence and level of biomarkers in patients to select those who will respond and benefit from the treatment. The development of new technologies and the upgrades of the known ones contribute to the innovations in molecular characterization of cancer, which allows the detection of patient’s mutational status with high sensitivity and specificity. Purpose: Here, we discuss the utilization of the third-generation type of polymerase chain reaction (PCR), droplet digital PCR (ddPCR), in the molecular diagnostics of oncology diseases. According to the studies reported in our review, ddPCR represents a promising tool in genetic profiling of cancer patients. Therefore, the optimization and precise validation may enable gradual implementation of ddPCR into clinical practice in the field of oncology.
OBJECTIVE: The aim of the study was to analyse the occurrence of lead in selected samples of fruit distilled spirits for own consumptions in terms of possible contribution to the occurrence of alcohol-attributable diseases. METHODS: In a pilot study, we analysed 18 samples of fruit spirits for own consumption. Most of the samples were distilled in the local growing distilleries in the Žilina Region with exception of 3 samples collected in the Trnava Region (one of them was of Hungarian origin). Sample preparation included previous mineralization with use of microwave decomposition system Multiwave 60 50 Hz. The samples were analysed by atomic absorption spectroscopy with graphic furnace (AAS GBC XplorAA 5000 with GF 5000). RESULTS: The average ethanol level in our samples was higher in comparison with distributed spirits. We detected lead in all samples. In two of them the concentration was lower than the limit of quantitation (LOQ). The highest lead concentrations were observed in plum spirit from Hungary (581.0 μg/l), and in grape spirit made in the Trnava Region (466.3 μg/l). CONCLUSIONS: Lead is a widespread contaminant of fruit spirits prepared for own consumption. Taking into consideration its common occurrence and possible multiplicative effect with ethanol, we can assume that lead can contribute to the occurrence of several alcohol-attributable chronic diseases. Due to the insufficient information in this field, our results provide significant insight into the issue and present an important starting point for further research.
- MeSH
- alkoholické nápoje analýza MeSH
- kontaminace potravin analýza MeSH
- lidé MeSH
- manipulace s potravinami * metody MeSH
- olovo * MeSH
- ovoce chemie MeSH
- pilotní projekty MeSH
- veřejné zdravotnictví MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Maďarsko MeSH
The proto-oncogene KRAS belongs among the most frequently mutated genes in all types of cancer and is also very important oncogene related to colorectal tumors. The detection of mutations in this gene in primary tumor is a predictive biomarker for the anti-EGFR therapy in metastatic CRC (mCRC); however, the patients with wild-type KRAS can also show resistance to the personalized medicine. The droplet-based digital PCR technology has improved the analytical sensitivity of the mutations detection, which led us to the idea about the optimization of this approach for KRAS testing. In this study, we report the application of ddPCR technology in order to analyze the presence of KRAS mutations in primary tumor and matched metastasis in lymph nodes (LNs) from patients with mCRC and address the question, whether the improvement in the detection method can lower the discrepancies of KRAS mutations detection between the primary tumor and regional LNs. Genomic DNA with wtKRAS and commercial DNA with mtKRAS (G12D) were used to set up the ddPCR reaction. Formalin-fixed paraffin-embedded tissues from primary tumor and positive lymph node from 31 patients with mCRC were analyzed using ddPCR and Sanger sequencing. KRAS status of primary tumors was known; however, the mutation status of lymph nodes was not detected previously. From 31 samples of primary tumors, our results corresponded to results from IVD kit in 30 cases. For one patient, ddPCR detected KRAS mutation in comparison with negative result of the IVD kit. In the samples of metastatic infiltrated LNs, ddPCR detected 16 samples as a WT KRAS and 15 lymph nodes showed positivity for KRAS mutation, whereby Sanger sequencing found KRAS mutations in 8 cases only. We also found two cases where genetic conditions of KRAS gene differed between primary tumor and infiltrated lymph node, both "low-grade" adenocarcinoma. Our study approved that ddPCR method is adequate technique with high sensitivity and in the future may be used as a diagnostic tool for evaluation of KRAS mutations, especially in infiltrated LNs of patients with mCRC.
- MeSH
- kolon patologie MeSH
- kolorektální nádory diagnóza genetika patologie MeSH
- lidé MeSH
- lymfatické uzliny patologie MeSH
- molekulární patologie metody MeSH
- mutantní proteiny genetika MeSH
- polymerázová řetězová reakce metody MeSH
- protoonkogenní proteiny p21(ras) genetika MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
The development of the new technologies such as the next-generation sequencing (NGS) makes more accessible the diagnosis of genetically heterogeneous diseases such as Lynch syndrome (LS). LS is one of the most common hereditary form of colorectal cancer. This autosomal dominant inherited disorder is caused by deleterious germline mutations in one of the mismatch repair (MMR) genes - MLH1, MSH2, MSH6 or PMS2, or the deletion in the EPCAM gene. These mutations eventually result in microsatellite instability (MSI), which can be easily tested in tumor tissue. According to the actual recommendations, all patients with CRC that are suspect to have LS, should be offered the MSI testing. When the MSI is positive, these patients should be recommended to genetic counseling. Here we report a pilot study about the application of NGS in the LS diagnosis in patients considered to have sporadic colorectal cancer. The inclusion criteria for the NGS testing were MSI positivity, BRAF V600E and MHL1 methylation negativity. We have used 5 gene amplicon based massive parallel sequencing on MiSeq platform. In one patient, we have identified a new pathogenic mutation in the exon 4 of the MSH6 gene that was previously not described in ClinVar, Human Gene Mutation Database, Ensembl and InSight databases. This mutation was confirmed by the Sanger method. We have shown that the implementation of new criteria for colorectal patients screening are important in clinical praxis and the NGS gene panel testing is suitable for routine laboratory settings.
- MeSH
- dědičné nepolypózní kolorektální nádory diagnóza genetika MeSH
- lidé MeSH
- mikrosatelitní nestabilita MeSH
- oprava chybného párování bází DNA MeSH
- pilotní projekty MeSH
- vysoce účinné nukleotidové sekvenování * MeSH
- zárodečné mutace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Slovenská republika MeSH
Papilomavírusy patria medzi vírusy s dvojvláknovou DNA (dsDNA). Sú schopné navodiť tak tvorbu benígnych, ako aj malígnych nádorov. Spojitosť medzi infekciou ľudskými papilomavírusmi (HPV) a rakovinou krčka maternice bola detailne opísaná len nedávno vďaka profesorovi zur Hausenovi. Avšak existujú zástupcovia HPV vírusov, u ktorých nebola dokázaná asociácia s vytváraním malignít. Preto rozoznávame tzv. vysoko-(HR) a nízkorizikové (LR) typy papilómov. V našej práci opisujeme životný cyklus HPV, molekulárne mechanizmy počas onkogenézy a snažíme sa o porovnanie HR HPV a LR HPV.
Papillomaviruses belong to a group of viruses with double-stranded DNA (dsDNA). These viruses are believed to induce benign as well as malignant tumour growth. Thanks to professor zur Hausen, the connection between the infection by human papillomaviruses (HPV) and cervix cancer was described in detail a few years ago. However, there exist certain types of HPV viruses, in which no association with malignancies was ever demonstrated. Hence, we can divide HPV into „high-risk“ (HR) and „low-risk“ (LR) group. Our work describes the life cycle of HPV, molecular mechanisms of oncogenesis and aims to compare HR HPV and LR HPV within these terms. Key words: viral cell transformation – oncogene protein E6 – oncogene protein E7 – E5 protein HPV-16 – „high-risk“ – „low-risk“ The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study. The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers. Submitted: 28. 6. 2013 Accepted: 14. 7. 2013
- MeSH
- Alphapapillomavirus MeSH
- DNA virů genetika MeSH
- infekce DNA virem * MeSH
- infekce papilomavirem * genetika MeSH
- interferony MeSH
- lidé MeSH
- nádorová transformace buněk MeSH
- nádorový supresorový protein p53 MeSH
- onkogenní proteiny virové * genetika metabolismus MeSH
- Papillomavirus E7 - proteiny MeSH
- retinoblastomový protein MeSH
- Check Tag
- lidé MeSH
